{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:15:34Z","timestamp":1789773334980,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.cyto.2022.156117","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T16:54:09Z","timestamp":1672332849000},"page":"156117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["A novel signature of interleukins 36\u03b1, 37, 38, 39 and 40 in ankylosing spondylitis"],"prefix":"10.1016","volume":"162","author":[{"given":"Adhraa S.","family":"Jaber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali H.","family":"Ad'hiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2022.156117_b0005","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4329\/wjr.v7.i9.236","article-title":"Ankylosing spondylitis: A state of the art factual backbone","volume":"7","author":"Ghasemi-rad","year":"2015","journal-title":"World J. Radiol."},{"key":"10.1016\/j.cyto.2022.156117_b0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fimmu.2019.00035","article-title":"Ankylosing spondylitis: A trade off of HLA-B27, ERAP, and pathogen interconnections? Focus on Sardinia","volume":"10","author":"Paladini","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2022.156117_b0015","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.biopha.2018.01.108","article-title":"Immune cells involved in the pathogenesis of ankylosing spondylitis","volume":"100","author":"Rezaiemanesh","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cyto.2022.156117_b0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41413-019-0057-8","article-title":"Ankylosing spondylitis: etiology, pathogenesis, and treatments","volume":"7","author":"Zhu","year":"2019","journal-title":"Bone Res."},{"key":"10.1016\/j.cyto.2022.156117_b0025","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/03009742.2014.956142","article-title":"Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: A cross-sectional comparative study","volume":"44","author":"Sveaas","year":"2015","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.cyto.2022.156117_b0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.22631\/rr.2017.69997.1026","article-title":"Upregulation of transforming growth factor-B1 gene in ankylosing spondylitis patients","volume":"2","author":"Vaez","year":"2017","journal-title":"Rheumatol. Res."},{"key":"10.1016\/j.cyto.2022.156117_b0035","doi-asserted-by":"crossref","unstructured":"M. Braga, F.F. Lara-Armi, J.S.F. Neves, M.A. Rocha-Loures, M. de S. Terron-Monich, L.D. Bahls-Pinto, Q.A. de Lima Neto, J.M.V. Zacarias, A.M. Sell, J.E.L. Visentainer, Influence of IL10 (rs1800896) Polymorphism and TNF-\u03b1, IL-10, IL-17A, and IL-17F Serum Levels in Ankylosing Spondylitis, Front. Immunol. 12 (2021) 2502. https:\/\/doi.org\/10.3389\/fimmu.2021.653611.","DOI":"10.3389\/fimmu.2021.653611"},{"key":"10.1016\/j.cyto.2022.156117_b0040","first-page":"19","article-title":"Serum Level of Interleukin-37 and Expression of Its mRNA in Ankylosing Spondylitis Patients: Possible Role in Osteoporosis, Egypt","volume":"23","author":"Fawzy","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2022.156117_b0045","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.3389\/fimmu.2019.01412","article-title":"Structural basis of IL-1 family cytokine signaling","volume":"10","author":"Fields","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2022.156117_b0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/5584_2020_488","article-title":"Interleukin-36: Structure, Signaling and Function","volume":"21","author":"Zhou","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.cyto.2022.156117_b0055","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3389\/fimmu.2019.02532","article-title":"Biology of il-36 signaling and its role in systemic inflammatory diseases","volume":"10","author":"Yuan","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2022.156117_b0060","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/jir.2018.0089","article-title":"Interleukin 30 to Interleukin 40","volume":"38","author":"Catalan-Dibene","year":"2018","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.cyto.2022.156117_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-015-0394-3","article-title":"Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity","volume":"13","author":"Chen","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cyto.2022.156117_b0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cytogfr.2018.01.001","article-title":"The enigmatic role of IL-38 in inflammatory diseases","volume":"39","author":"Garraud","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2022.156117_b0075","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/biom9080345","article-title":"IL-38: A new player in inflammatory autoimmune disorders","volume":"9","author":"Xie","year":"2019","journal-title":"Biomolecules."},{"key":"10.1016\/j.cyto.2022.156117_b0080","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/annrheumdis-2011-200439","article-title":"Association between the IL-1 family gene cluster and spondyloarthritis","volume":"71","author":"Monnet","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2022.156117_b0085","doi-asserted-by":"crossref","first-page":"214","DOI":"10.5114\/ceji.2020.97911","article-title":"Interleukin 39: a new member of interleukin 12 family","volume":"45","author":"Lu","year":"2020","journal-title":"Cent. Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2022.156117_b0090","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/eji.201546095","article-title":"A novel IL-23p19\/Ebi3 (IL-39) cytokine mediates inflammation in Lupus-like mice","volume":"46","author":"Wang","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2022.156117_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-03283-2","article-title":"Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections","volume":"12","author":"Gao","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cyto.2022.156117_b0100","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1074\/mcp.M112.018713","article-title":"Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis","volume":"11","author":"Zingaretti","year":"2012","journal-title":"Mol. Cell. Proteomics."},{"key":"10.1016\/j.cyto.2022.156117_b0105","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaut.2014.01.015","article-title":"The classification and diagnostic criteria of ankylosing spondylitis","volume":"48\u201349","author":"Raychaudhuri","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cyto.2022.156117_b0110","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10067-007-0755-2","article-title":"Defining disease status in ankylosing spondylitis: Validation and cross-cultural adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing Spondy","volume":"27","author":"El Miedany","year":"2008","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cyto.2022.156117_b0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3352\/jeehp.2021.18.17","article-title":"Sample size determination and power analysis using the G*Power software","volume":"18","author":"Kang","year":"2021","journal-title":"J. Educ. Eval. Health Prof."},{"key":"10.1016\/j.cyto.2022.156117_b0120","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.molimm.2013.07.016","article-title":"Inflammatory pathways in spondyloarthritis","volume":"57","author":"Hreggvidsdottir","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cyto.2022.156117_b0125","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fcell.2019.00317","article-title":"Function and Regulation of IL-36 Signaling in Inflammatory Diseases and Cancer Development","volume":"7","author":"Queen","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cyto.2022.156117_b0130","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.4049\/jimmunol.1301481","article-title":"IL-36 Promotes Myeloid Cell Infiltration, Activation, and Inflammatory Activity in Skin","volume":"192","author":"Foster","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2022.156117_b0135","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3390\/ijms20071649","article-title":"IL-36 cytokines: Regulators of inflammatory responses and their emerging role in immunology of reproduction","volume":"20","author":"Murrieta-Coxca","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2022.156117_b0140","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/mi.2015.134","article-title":"IL-36\u03b1 expression is elevated in ulcerative colitis and promotes colonic inflammation","volume":"9","author":"Russell","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.cyto.2022.156117_b0145","doi-asserted-by":"crossref","unstructured":"H. song Xia, Y. Liu, Y. Fu, M. Li, Y. qing Wu, Biology of interleukin-38 and its role in chronic inflammatory diseases, Int. Immunopharmacol. 95 (2021) 107528. https:\/\/doi.org\/10.1016\/j.intimp.2021.107528.","DOI":"10.1016\/j.intimp.2021.107528"},{"key":"10.1016\/j.cyto.2022.156117_b0150","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.immuni.2019.03.011","article-title":"The Immunobiology of the Interleukin-12 Family: Room for Discovery","volume":"50","author":"Tait Wojno","year":"2019","journal-title":"Immunity."},{"key":"10.1016\/j.cyto.2022.156117_b0155","first-page":"1660","article-title":"Anti-IL-39 (IL-23p19\/Ebi3) polyclonal antibodies ameliorate autoimmune symptoms in lupus-like mice","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cyto.2022.156117_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102430","article-title":"Elevated serum interleukin-39 levels in patients with neuromyelitis optica spectrum disorders correlated with disease severity","volume":"46","author":"Yang","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.cyto.2022.156117_b0165","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24284","article-title":"Low levels of serum IL-39 are associated with autoimmune thyroid disease","volume":"36","author":"Weng","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.cyto.2022.156117_b0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.745523","article-title":"IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibodies, and NETosis","volume":"12","author":"Navr\u00e1tilov\u00e1","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2022.156117_b0175","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.4049\/jimmunol.1700534","article-title":"Identification of IL-40, a Novel B Cell-Associated Cytokine","volume":"199","author":"Catalan-Dibene","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2022.156117_b0180","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3892\/etm.2021.10108","article-title":"Characteristics of the intestinal microbiome in ankylosing spondylitis","volume":"22","author":"Cardoneanu","year":"2021","journal-title":"Exp. Ther. Med."}],"updated-by":[{"DOI":"10.1016\/j.cyto.2023.156195","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000}}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662200326X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662200326X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T19:03:56Z","timestamp":1715195036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104346662200326X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":36,"alternative-id":["S104346662200326X"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2022.156117","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel signature of interleukins 36\u03b1, 37, 38, 39 and 40 in ankylosing spondylitis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2022.156117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"156117"}}